Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
03/1999
03/16/1999US5882868 Method of diagnosing spinal muscular atrophy
03/16/1999US5882867 Detection of nucleic acids by formation of template-dependent product
03/16/1999US5882866 Preventing complex formation between antigen binding protein and non-nucleic acid immunogen; genetic engineering
03/16/1999US5882865 Cancer drug screen based on cell cycle uncoupling
03/16/1999US5882864 Biomarkers and targets for diagnosis, prognosis and management of prostate disease
03/16/1999US5882863 Method of measuring nucleic acids and reagent used therefor
03/16/1999US5882862 Human radioresistance/cell cycle progression gene
03/16/1999US5882860 Hybridization of nucleic acid derived from cell with polynucleotide; genetic engineering; suppressing gene expression
03/16/1999US5882857 Forming multiple copies of a target sequence of a target polynucleotide
03/16/1999US5882856 Primers that allow multiplex pcr reactions to be designed and carried out without elaborate optimization steps, irrespective of the potentially divergent properties of the different primers used.
03/16/1999US5882855 DNA encoding a human dopamine D1 receptor and uses thereof
03/16/1999US5882852 Hepatitic C virus (HCV) core gene nucleotide sequences and related methods of detecting major and minor genotypes of HCV isolates
03/16/1999US5882643 Identification and characterization of such factors which can play a role in preventing, ameliorating or correcting infections, dysfunctions or diseases. a novel lep gene of streptococcus pneumoniae.
03/16/1999US5882595 Automatic processing system for use in solid phase biospecific binding and DNA sequencing techniques
03/16/1999US5882494 Reaction products of a diisocyanate, a hydrophilic diol or diamine, and a silicone material, increasing oxygen permeability and decreased analyte (e.g. glucose) permeability
03/16/1999CA2244232A1 Novel def
03/16/1999CA2236363A1 Novel compound
03/16/1999CA1340449C Expression of dna sequences derived from nocardioform microorganisms
03/15/1999CA2246274A1 Automated incubator and reader for nucleic acid assays
03/12/1999CA2215349A1 Method of detecting gene expression and/or of preventing such expression in cells
03/11/1999WO1999012034A1 Amine compounds and combinatorial libraries comprising same
03/11/1999WO1999012033A2 Method and kit for identifying interactions between proteins or peptides
03/11/1999WO1999012032A1 A method for the evaluation of antiviral drugs
03/11/1999WO1999012031A1 A method of genotyping
03/11/1999WO1999012027A1 Modulators of dna cytosine-5 methyltransferase and methods for use thereof
03/11/1999WO1999012016A1 Microfluidic system with electrofluidic and electrothermal controls
03/11/1999WO1999012015A2 Methods for the rapid detection and enumeration of viable microorganisms
03/11/1999WO1999011824A1 An alpha-2 macroglobulin diagnostic test
03/11/1999WO1999011823A2 Selection of pcr primer pairs to amplify a group of nucleotide sequences
03/11/1999WO1999011822A1 Method for predicting prognosis and treatment response for genetically based abnormalities
03/11/1999WO1999011820A1 Compositions and methods for the identification and quantitation of deletion sequence oligonucleotides in synthetic oligonucleotide preparations
03/11/1999WO1999011819A1 Improved detection of mutations in nucleic acids by chemical cleavage
03/11/1999WO1999011818A1 Method for detecting highly functional polypeptides or nucleic acids
03/11/1999WO1999011817A1 Screening method for determining individuals at risk of developing diseases associated with different polymorphic forms of wildtype p53
03/11/1999WO1999011816A1 Reagents for testing cleanness and methods for testing cleanness
03/11/1999WO1999011815A1 Test method for peroxidase
03/11/1999WO1999011814A1 Assays for detecting modulators of cytoskeletal function
03/11/1999WO1999011813A2 Oligonucleotide probes bearing quenchable fluorescent labels, and methods of use thereof
03/11/1999WO1999011811A1 Methods of measuring gene expression using wax-embedded tissue specimens
03/11/1999WO1999011801A2 Protease based gene switching system
03/11/1999WO1999011798A1 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells
03/11/1999WO1999011788A1 Kringle1
03/11/1999WO1999011787A1 DNA PARTICIPATING IN REGULATION OF EXPRESSION O PEBP2 αA GENE, AND USE THEREOF
03/11/1999WO1999011785A1 Chimeric binding peptide library screening method
03/11/1999WO1999011780A2 Conductine protein and a related agent for diagnosing and treating tumor illnesses
03/11/1999WO1999011777A1 Methods for protein screening
03/11/1999WO1999011774A1 Polypeptides comprising a coiled-coil and an addition site
03/11/1999WO1999011772A1 Transgenic animals for the study of biological, physical and chemical toxic agents
03/11/1999WO1999011766A1 Luminescence method for luciferin/luciferase system and luminescent reagent
03/11/1999WO1999011764A2 Methods for generating high titer helper-free preparations of recombinant aav vectors
03/11/1999WO1999011760A1 DIFFERENTIAL LIGAND ACTIVATION OF ESTROGEN RECEPTORS ERα AND ERβ AT AP1 SITES
03/11/1999WO1999011754A1 Dna capillary
03/11/1999WO1999011753A1 SpoOJ2 OF STAPHYLOCOCCUS AUREUS
03/11/1999WO1999011663A1 HUMAN DEFENSIN DEF-X, GENE AND DNAc, COMPOSITION CONTAINING SAME AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS
03/11/1999WO1999011660A2 Immunogenic polypeptides that mimic a surface polysaccharide antigen of a pathogenic microorganism, method for obtaining the same, and their use in vaccine compositions
03/11/1999WO1999011654A1 Randomly generated glycopeptide combinatorial libraries
03/11/1999WO1999011293A1 50 human secreted proteins
03/11/1999WO1998058086A3 Nucleic acid primers and probes for detecting hiv-1 and hiv-2
03/11/1999WO1998058083A3 Method for quantitative measurement of gene expression using multiplex competitive reverse transcriptase-polymerase chain reaction
03/11/1999WO1998057986A3 Human preprotachykinin b
03/11/1999WO1998057984A3 Torsin, torsin genes, and methods of use
03/11/1999WO1998055512A3 Smad-interacting polypeptides and their use
03/11/1999WO1998055507A3 Modulators of intracellular inflammation, cell death and cell survival pathways containing a card and kinase domain
03/11/1999WO1998054212A3 Human type 3 ryanodine receptor protein and dna molecules coding therefor
03/11/1999WO1998053104A3 Detection of retroviral subtypes based upon envelope specific sequences
03/11/1999WO1998053097A3 Method for isolation of biosynthesis genes for bioactive molecules
03/11/1999WO1998046258A3 Use of chondroitinase in the manufacture of a medicament in the treatment and prevention of mucoid secretions
03/11/1999WO1998045700A3 Method for the mass spectrometric sequencing of biopolymers
03/11/1999WO1998042847A3 Papilloma virus main capsid protein and the use thereof in diagnosis, therapy and vaccination
03/11/1999WO1998033509A3 Useful properties of human lactoferrin and variants thereof
03/11/1999DE19739611A1 Nucleinsäure-Sequenzen und Verfahren zum Nachweis von Bakterien der Gattung Pseudomonas Nucleic acid sequences and methods for detecting bacteria of the genus Pseudomonas
03/11/1999DE19738908A1 Assessing genetic susceptibility to neuro-dermatitis and asthma
03/11/1999DE19738816A1 Verfahren zur Markierung von festen, flüssigen oder gasförmigen Substanzen A method for marking solid, liquid or gaseous substances
03/11/1999DE19738626A1 Microflow cuvette for continuous observation of widely-ranging microscopic organisms and particles
03/11/1999CA2830694A1 Methods for generating high titer helper-free preparations of recombinant aav vectors
03/11/1999CA2682108A1 Methods for generating high titer helper-free preparations of recombinant aav vectors
03/11/1999CA2303418A1 Dna participating in regulation of expression o pebp2 .alpha.a gene, and use thereof
03/11/1999CA2302829A1 An alpha-2 macroglobulin diagnostic test
03/11/1999CA2302472A1 Randomly generated glycopeptide combinatorial libraries
03/11/1999CA2302394A1 Polypeptides comprising a coiled-coil and an addition site
03/11/1999CA2302220A1 Transgenic animals for the study of biological, physical and chemical toxic agents
03/11/1999CA2301633A1 Method and kit for identifying interactions between proteins or peptides
03/11/1999CA2301143A1 Differential ligand activation of estrogen receptors er.alpha. and er.beta. at ap1 sites
03/11/1999CA2300869A1 Assays for detecting modulators of cytoskeletal function
03/11/1999CA2300354A1 Modulators of dna cytosine-5 methyltransferase and methods for use thereof
03/11/1999CA2300203A1 Microfluidic system with electrofluidic and electrothermal controls
03/11/1999CA2296758A1 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells
03/11/1999CA2268368A1 Improved detection of mutations in nucleic acids by chemical cleavage
03/10/1999EP0901018A2 Method for quantitative measurement of a substrate
03/10/1999EP0900848A2 MecB polynucleotides and polypeptides from the Clpc ATPase family of Stapyloccoccus aureus
03/10/1999EP0900846A2 Nucleic acid encoding Streptococcus pneumoniae response regulator
03/10/1999EP0900845A2 Signal recognition particle polypeptides and polynucleotides
03/10/1999EP0900843A2 FfH polypeptide from Streptococcus
03/10/1999EP0900805A2 Incorporation of selectably cleavable and/or abasic sites into oligonucleotide chains and reagents therefor
03/10/1999EP0900384A2 Novel treatment
03/10/1999EP0900376A1 Biodetectors targeted to specific ligands
03/10/1999EP0900286A1 HIGH VOLUME IN-SITU mRNA HYBRIDIZATION METHOD FOR THE QUANTIFICATION AND DISCOVERY OF DISEASE SPECIFIC GENES
03/10/1999EP0900284A1 Novel reagent, method, and kit for the quantitation of oxidation-reduction phenomena in proteins and peptides
03/10/1999EP0900277A1 Nucleic acid molecules which code the potato debranching enzyme
03/10/1999EP0900276A1 Novel cyclin-selective ubiquitin carrier polypeptides